Immune profiling reveals increased mortality and risk stratification in SFTS with hemophagocytic lymphohistiocytosis, suggesting improved patient outcomes.
SFTS complicated by HLH is characterized by immune dysregulation, high viral burden, and increased mortality. Early recognition of HLH and immune-virological surveillance may aid risk stratification and improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
zou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: